(Q39559370)

English

A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities

scientific article published on November 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities (English)

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

author name string

A A Firsov

1

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

S N Vostrov

2

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

A A Shevchenko

3

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Y A Portnoy

4

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

S H Zinner

5

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

language of work or name

0 references

publication date

1 November 1998

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

42

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

11

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

2841-2847

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

In vitro models for the study of antibiotic activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Quantitative analysis of antimicrobial effect kinetics in an in vitro dynamic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

14 September 2017

Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

25 September 2017

In vitro simulated pharmacokinetics profiles: forecasting antibiotic optimal dosage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

25 September 2017

Antibacterial activity of cefpodoxime proxetil in a pharmacokinetic in-vitro model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=105953

15 June 2018

Influence of ampicillin elimination half-life on in-vitro bactericidal effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/9797213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The comparative pharmacokinetics of five quinolones

1 reference

https://pubmed.ncbi.nlm.nih.gov/9797213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic considerations in quinolone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9797213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae

1 reference

https://pubmed.ncbi.nlm.nih.gov/9797213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of quinolones

1 reference

https://pubmed.ncbi.nlm.nih.gov/9797213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the pharmacodynamic properties of quinolones

1 reference

https://pubmed.ncbi.nlm.nih.gov/9797213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/9797213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9797213

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39559370&oldid=1773857778"